Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Impact of cagrilintide 2.4 mg on physical function – post hoc patient-reported outcomes from REDEFINE 1

Authors :

D. Rubino¹; R.M. Abschneider²; M. Blüher³; S.M. Bernt Jørgensen²; R.L. Kolotkin^4,5; D. Li²; K.H. Pietiläinen⁶; M. Ried-Larsen2, T. Wadden⁷

Affiliations

View Details Hide Details

Download the poster (.pdf)

Keywords

Obesity

Congress short oral presentation

Amylin

CagriSema

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

Impact of cagrilintide 2.4 mg on physical function – post hoc patient-reported outcomes from REDEFINE 1​

Impact of cagrilintide 2.4 mg on physical function – post hoc patient-reported outcomes from REDEFINE 1